VALIANTLAB2026-01-012026-03-31VALIANTLAB2026-03-31VALIANTLAB2025-03-31VALIANTLAB2025-04-012026-03-31VALIANTLAB2026-01-012026-03-31in-capmkt:OtherExpenses1MemberVALIANTLAB2025-04-012026-03-31in-capmkt:OtherExpenses1MemberVALIANTLAB2026-03-31OtherNoncurrentFinancialAssetsDomain1VALIANTLAB2026-03-31OtherNoncurrentAssetsDomain1VALIANTLAB2026-03-31OtherCurrentAssetsDomain1VALIANTLAB2026-03-31OtherNoncurrentFinancialLiabilitiesDomain1VALIANTLAB2026-03-31OtherNoncurrentFinancialLiabilitiesDomain2VALIANTLAB2026-03-31OtherCurrentFinancialLiabilitiesDomain1VALIANTLAB2026-03-31OtherCurrentFinancialLiabilitiesDomain2VALIANTLAB2026-03-31OtherCurrentLiabilitiesDomain1VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain1VALIANTLAB2025-12-31RelatedPartyTransactionDomain1VALIANTLAB2026-03-31RelatedPartyTransactionDomain1VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain2VALIANTLAB2025-12-31RelatedPartyTransactionDomain2VALIANTLAB2026-03-31RelatedPartyTransactionDomain2VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain3VALIANTLAB2025-12-31RelatedPartyTransactionDomain3VALIANTLAB2026-03-31RelatedPartyTransactionDomain3VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain4VALIANTLAB2025-12-31RelatedPartyTransactionDomain4VALIANTLAB2026-03-31RelatedPartyTransactionDomain4VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain5VALIANTLAB2025-12-31RelatedPartyTransactionDomain5VALIANTLAB2026-03-31RelatedPartyTransactionDomain5VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain6VALIANTLAB2025-12-31RelatedPartyTransactionDomain6VALIANTLAB2026-03-31RelatedPartyTransactionDomain6VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain7VALIANTLAB2025-12-31RelatedPartyTransactionDomain7VALIANTLAB2026-03-31RelatedPartyTransactionDomain7VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain8VALIANTLAB2025-12-31RelatedPartyTransactionDomain8VALIANTLAB2026-03-31RelatedPartyTransactionDomain8VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain9VALIANTLAB2025-12-31RelatedPartyTransactionDomain9VALIANTLAB2026-03-31RelatedPartyTransactionDomain9VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain10VALIANTLAB2025-12-31RelatedPartyTransactionDomain10VALIANTLAB2026-03-31RelatedPartyTransactionDomain10VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain11VALIANTLAB2025-12-31RelatedPartyTransactionDomain11VALIANTLAB2026-03-31RelatedPartyTransactionDomain11VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain12VALIANTLAB2025-12-31RelatedPartyTransactionDomain12VALIANTLAB2026-03-31RelatedPartyTransactionDomain12VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain13VALIANTLAB2025-12-31RelatedPartyTransactionDomain13VALIANTLAB2026-03-31RelatedPartyTransactionDomain13VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain14VALIANTLAB2025-12-31RelatedPartyTransactionDomain14VALIANTLAB2026-03-31RelatedPartyTransactionDomain14VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain15VALIANTLAB2025-12-31RelatedPartyTransactionDomain15VALIANTLAB2026-03-31RelatedPartyTransactionDomain15VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain16VALIANTLAB2025-12-31RelatedPartyTransactionDomain16VALIANTLAB2026-03-31RelatedPartyTransactionDomain16VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain17VALIANTLAB2025-12-31RelatedPartyTransactionDomain17VALIANTLAB2026-03-31RelatedPartyTransactionDomain17VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain18VALIANTLAB2025-12-31RelatedPartyTransactionDomain18VALIANTLAB2026-03-31RelatedPartyTransactionDomain18VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain19VALIANTLAB2025-12-31RelatedPartyTransactionDomain19VALIANTLAB2026-03-31RelatedPartyTransactionDomain19VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain20VALIANTLAB2025-12-31RelatedPartyTransactionDomain20VALIANTLAB2026-03-31RelatedPartyTransactionDomain20VALIANTLAB2026-01-012026-03-31RelatedPartyTransactionDomain21VALIANTLAB2025-12-31RelatedPartyTransactionDomain21VALIANTLAB2026-03-31RelatedPartyTransactionDomain21VALIANTLAB2026-01-012026-03-31AuditorDomain1VALIANTLAB2026-03-31Statement1VALIANTLAB2026-01-012026-03-31Statement1VALIANTLAB2026-03-31StatementDynamic1I1Statement1VALIANTLAB2026-03-31StatementDynamic1I2Statement1VALIANTLAB2026-03-31StatementDynamic1I3Statement1VALIANTLAB2026-03-31StatementDynamic1I4Statement1VALIANTLAB2026-03-31StatementDynamic1I5Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares543998VALIANTLABNOTLISTEDINE0JWS01017Valiant Laboratories LimitedMain BoardEquity2025-04-012026-03-312026-05-142026-05-11INRLakhsQuarterlyFourth quarterSingle segmentManufacturing Chemical2026-05-1415:30:002026-05-1417:30:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2026-02-11https://www.valiantlabs.in/assets/images/investors/related_party_transactions.pdftrue1falseThis disclosure is not applicable, as the Company has not defaulted on any of its loans or debt securities.2026-01-012026-03-31AuditedStandalone65303400077270006607610004950430002478300021885000129070001720005212000534100006134120004734900004734900010488000153300012021000035328000000035328000-12500035203000543125000100.650.7000.650.70001. The above results for the Quarter and year ended 31st March,2026 have been reviewed by the Audit Committee in their meeting held on 14th May,2026 and approved by the Board of Directors in their meeting held on 14th May,2026. <BR> <BR> 2 The Company is operating as a single segment company, engaged in manufacturing of chemicals business, and hence there is no separate reportable business segment. <BR> <BR> 3 The aforesaid Audited Financial results will be uploaded on the company's website www.valiantlabs.in and will also be available on the websites of BSE Limited i.e. www.bseindia.com / NSE Limited i.e www.nseindia.com <BR> <BR> 4 Figures for the previous period have been regrouped or rearranged wherever necessary. <BR> 2025-04-012026-03-31AuditedStandalone2170425000289480002199373000171527500015565300021380005003600026110002261900017556200021238940007547900007547900016621000337600019997000055482000000055482000-43000554390004345000001026544620001.021.1001.021.1000Other Expenses53410000Other Expenses1755620002959140003573000008000000001650580000001455000016651300000300000196571700022970400025980200083254800030730000351740003690001158623000817100049671600018932140000038589310005431250002654462000319758700031975870000175920001759200010730001589000003455500001616000600135000601751000180410006197920004880000211700000626789000006613440003858931000Other Financial Assets14550000Other non-current assets300000Other current assets496716000Lease Liabilities7978000Other non-current financial liabilities9614000Other current financial liabilities13386000Lease Liabilities4655000Other current liabilities4880000the Company does not have separately identifiable operating segments. As such, segment reporting is not applicable for the purpose of financial results.2611000-190146000-1115460000-354272000-3000001365700000407744000060720005464000226190000217000765000273500000000-111510000023400018420000-203455000-127976000000100880000-13806400000025980200000002760001159800000000000000000000000190226000-80898000001086250000000005940020000026110000689691000201703000-172590000-1725900047989000307300001250004300000-125000-43000Valiant Laboratories Limited******Santosh Vora******Executive Director(MD)Remuneration2700000NA135000000Valiant Laboratories Limited******Paresh Shah******Executive Director(CFO)Remuneration1500000NA75000000Valiant Laboratories Limited******Valiant Advanced Sciences Private Limited******Wholly Owned SubsidiaryInvestment1650580000NA016505800001650580000Valiant Laboratories Limited******Valiant Advanced Sciences Private Limited******Wholly Owned SubsidiarySale of goods or services2000000000NA656490003029500066025000Valiant Laboratories Limited******Valiant Advanced Sciences Private Limited******Wholly Owned SubsidiaryAny other transactionOther Reimbursement20000000NA84300018140001320000Valiant Laboratories Limited******Valiant Advanced Sciences Private Limited******Wholly Owned SubsidiaryAny other transactionTrade Advance Given100000000NA27463600018439000293075000Valiant Laboratories Limited******Valiant Advanced Sciences Private Limited******Wholly Owned SubsidiaryPurchase of goods or services100000000NA205912000370000Valiant Laboratories Limited******Valiant Organics Limited******Ultimate Holding CompanyPurchase of goods or services3000000000NA650811000104454000549606000Valiant Laboratories Limited******Shantilal Vora******Non Executive DirectorAny other transactionSitting FeesNA2300000Valiant Laboratories Limited******Aarti Pharmalabs Limited******Other Related PartyAny other transactionSecurity Deposit received against Leave & License Agreement executed9614000NA096140009614000Valiant Laboratories Limited******Aarti Pharmalabs Limited******Other Related PartyPurchase of goods or services70000000NA1804600077600003111000Valiant Laboratories Limited******Aarti Pharmalabs Limited******Other Related PartyAny other transactionRent Received50000000NA1500000029500000Valiant Laboratories Limited******Aarti Pharmalabs Limited******Other Related PartyAny other transactionOther Reimbursement100000000NA3784400057370006581000Valiant Advanced Sciences Private Limited******Valiant Organics Limited******Ultimate Holding CompanySale of goods or services500000000NA1012400002822000Valiant Advanced Sciences Private Limited******Dhanvallabh Ventures LLP******Holding CompanyPurchase of goods or services40000000ominbus approval granted on 11-11-20259810002025-11-11375600000During the period 1-Oct-25 to 31-March-26, Valiant Advanced Sciences Private Limited entered into a transaction of purchase of goods from Dhanvallabh Ventures LLP amounting to Rs. 37.56 lakhs, out of which the transaction of Rs. 9.81 was ratified by the Audit Committee in its meeting dated 11-11-2025 and further granted an omnibus approval of Rs. 400 lakhs in the said meeting.Valiant Advanced Sciences Private Limited******Aarti Pharmalabs Limited******Other Related PartySale of goods or servicesNA421100004969000Valiant Advanced Sciences Private Limited******Alchemie Speciality Chemicals Pvt.Ltd******Ultimate Holding CompanySale of goods or services150000000NA10808000012753000Valiant Advanced Sciences Private Limited******J.B.Singh******Executive DirectorRemuneration2500000NA85000000Valiant Laboratories Limited******Aarti Pharmalabs Limited******Other Related PartySale of goods or services70000000NA49072000029033000Valiant Laboratories Limited******Aarti Industries Limited******Other Related PartyPurchase of goods or services0NA14690002026-02-11146900000Valiant Laboratories Limited******Valiant Advanced Sciences Private Limited******Wholly Owned SubsidiaryAny other transactionCommission received on Corporate Guarantee provided0NA200002026-02-1120000001351174000AuditedtrueRaman S. Shah & Co.true2029-02-28Rights Issues2025-08-118146880002026-03-31trueIndia Ratings & Research Private LimitedfalseNoneNoneNoneAkshay GangurdeCompany Secretary and Compliance OfficerMumbai2026-05-14Adjustment of Unsecured loans of Promoter/Promoter group towards Right Equity Shares application moneyNA58005100005800510000The said transaction is adjustment of unsecured loans of Promoter/Promoter group towards Right Equity shares application money (consideration in kind/other than cash) where no cash is involved i.e. 77,34,016 Rights Equity Shares of the Company is issue and allotted, for unsecured loan of INR 5800.51 Lakhs outstanding as on 08th July 2025 as stated in the letter of offer.Repayment of Outstanding loans of Existing promoters Dhanvallabh Ventures LLPNA139510000139510000Capital ExpenditureNA180380000127780000General Corporate PurposesNA19564800001982110000As informed by the Company, actual issue expenses are INR 44.37 Lakhs against INR 70.00 Lakhs as mentioned in the offer document. The balance of INR 25.63 Lakhs is adjusted towards General Corporate PurposesIssue Related ExpensesNA7000000044370000As informed by the Company, actual issue expenses are INR 44.37 Lakhs against INR 70.00 Lakhs as mentioned in the offer document. The balance of INR 25.63 Lakhs is adjusted towards General Corporate Purposes.